CD19 and diffuse large B-cell lymphoma: In addition, oncogenes important for proliferation in DLBCL (MYC) and associated with T cell proliferation and activation (CD69) were also found in this upregulated group, as well as a B-cell marker (CD19), a receptor kinase signaling (NRP1), an angiogenesis inductor (NOS3) and a tumor progression inducer (PDGRFA).